183 related articles for article (PubMed ID: 28276561)
1. The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation.
Gao G; Zhang M; Gong D; Chen R; Hu X; Sun T
Nanoscale; 2017 Mar; 9(12):4107-4113. PubMed ID: 28276561
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Mechanism of Inhibition of Au Nanoparticles on the Aggregation of Amyloid-β(16-22) Peptides at the Atom Level by All-Atom Molecular Dynamics.
Song M; Sun Y; Luo Y; Zhu Y; Liu Y; Li H
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925792
[TBL] [Abstract][Full Text] [Related]
3. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Qu X
Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
[TBL] [Abstract][Full Text] [Related]
4. CLVFFA-Functionalized Gold Nanoclusters Inhibit Aβ40 Fibrillation, Fibrils' Prolongation, and Mature Fibrils' Disaggregation.
Hao S; Li X; Han A; Yang Y; Fang G; Liu J; Wang S
ACS Chem Neurosci; 2019 Nov; 10(11):4633-4642. PubMed ID: 31637909
[TBL] [Abstract][Full Text] [Related]
5. Isomeric Effect of Nano-Inhibitors on Aβ
Li J; Gao G; Tang X; Yu M; He M; Sun T
ACS Appl Mater Interfaces; 2021 Feb; 13(4):4894-4904. PubMed ID: 33486955
[TBL] [Abstract][Full Text] [Related]
6. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
[TBL] [Abstract][Full Text] [Related]
7. Effects of Gold Nanospheres and Nanocubes on Amyloid-β Peptide Fibrillation.
Wang W; Han Y; Fan Y; Wang Y
Langmuir; 2019 Feb; 35(6):2334-2342. PubMed ID: 30636427
[TBL] [Abstract][Full Text] [Related]
8. How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?
Kim Y; Park JH; Lee H; Nam JM
Sci Rep; 2016 Jan; 6():19548. PubMed ID: 26782664
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
10. Composite of gold nanoclusters and basified human serum albumin significantly boosts the inhibition of Alzheimer's β-amyloid by photo-oxygenation.
Liu W; Zhang H; Dong X; Sun Y
Acta Biomater; 2022 May; 144():157-167. PubMed ID: 35301147
[TBL] [Abstract][Full Text] [Related]
11. Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.
Xiong N; Zhao Y; Dong X; Zheng J; Sun Y
Small; 2017 Apr; 13(13):. PubMed ID: 28112856
[TBL] [Abstract][Full Text] [Related]
12. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
Xia N; Zhou B; Huang N; Jiang M; Zhang J; Liu L
Biosens Bioelectron; 2016 Nov; 85():625-632. PubMed ID: 27240009
[TBL] [Abstract][Full Text] [Related]
13. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
Kang MK; Lee J; Nguyen AH; Sim SJ
Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer.
Lee H; Kim Y; Park A; Nam JM
Small; 2014 May; 10(9):1779-89. PubMed ID: 24664514
[TBL] [Abstract][Full Text] [Related]
15. The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation.
Corti R; Cox A; Cassina V; Nardo L; Salerno D; Marrano CA; Missana N; Andreozzi P; Silva PJ; Stellacci F; Dal Magro R; Re F; Mantegazza F
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033502
[TBL] [Abstract][Full Text] [Related]
16. Detection of Femtomolar Amyloid-β Peptides for Early-Stage Identification of Alzheimer's Amyloid-β Aggregation with Functionalized Gold Nanoparticles.
Chang YJ; Chien YH; Chang CC; Wang PN; Chen YR; Chang YC
ACS Appl Mater Interfaces; 2024 Jan; 16(3):3819-3828. PubMed ID: 38214471
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
19. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]